FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (âTernsâ or the âCompanyâ ) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that management will present at the 43 Annual J.P. Morgan Healthcare Conference on January 15, 2025 at 4:30 p.m. PT. A live webcast of the presentation will be available on the investor relations page of t ...

Management presenting at the 43 Annual J.P. Morgan Healthcare Conference on January 15 Company to host an Investor Day on January 28 in New York City MOUNTAIN VIEW, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced preliminary unaudited revenue for the quarter and year ended December 31, 2024 and provided business updates. NeuroPace plans to release its fourth quarter and full y ...

ABOUT PENNANTPARK FLOATING RATE CAPITAL LTD. MIAMI, Jan. 08, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) announced that it will report results for the first fiscal quarter ended December 31, 2024 on Monday, February 10, 2025 after the close of the financial markets. PennantPark Floating Rate Capital Ltd. is a business development company which primarily invests in U.S. middle-market private companies in the form of floating rate senior secured loans, includin ...

Investigational new drug (IND) applications for initiating first-in-human studies for ZW220 and ZW251 in solid tumors anticipated in 2025IND applications for initiating first-in-human studies for ZW209 and ZW1528 anticipated in 2026Phase 3 HERIZON-GEA-01 top-line results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive gastroesophageal adenocarcinoma (GEA) are expected 2Q-2025, with potential supplemental biologics license application (sBLA) by Jazz Pharmaceuticals later in 2025Potential regulato ...

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 43rd Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PT on Wednesday, January 15, 2025. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations page of Sana ...

CHICAGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the fourth quarter ending December 31, 2024 after market close on Tuesday, February 25, 2025. The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) on Tuesda ...

DANBURY, CT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) today announced that it will release its financial and operating results for the fiscal 2025 second quarter ended December 31, 2024, after the market closes on Wednesday, January 29, 2025. Following the earnings release, the Company will host a conference call with investors and analysts at 5:00 PM (Eastern Time) to discuss these results. The conference call will be webcast live from the Co ...

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced it plans to report new clinical data from the Phase 1/2 ACHIEVE clinical trial on January 10, 2025, and to host a webcast at 8:00 a.m. ET. The company intends to issue a press release prior to the start of the event. Investor Conference Call and ...

MIAMI, Jan. 08, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) announced that it will report results for the first fiscal quarter ended December 31, 2024 on Monday, February 10, 2025 after the close of the financial markets. The Company will also host a conference call at 12:00 p.m. (Eastern Time) on Tuesday, February 11, 2025 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing toll-free ...

Reports 1.1% Sequential Quarter Increase in Adjusted NII per Share (Excluding the Effect of the One- Time Interest Reserve Reversal) and Grows LTM ROE to 9.2% __________________________________________ Reports Strong Deployments of $84.5 Million, Supporting Two New Platforms and Eight Existing Portfolio Companies, Offset by Repayments NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE: SAR) (âSaratoga Investmentâ or âthe Companyâ ), a business development company (âBDCâ ), today ann ...